SRRM4 and posterior cortical atrophy: In untreated PCa-adeno, low SRRM4 expression was detected in approximately 16% of tumor cores, and PCa-adeno treated with neoadjuvant hormone therapy for over 7 months had critically higher SRRM4 expression [79].